Pacific Biosciences of California, Inc. (PACB)

PACB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	349	2,624	1,850	4,513	4,675	787
Market Cap Growth	-64.88%	41.85%	-59.02%	-3.45%	494.30%	-28.61%
Enterprise Value	718	2,925	2,024	4,422	4,397	799
PE Ratio	-	-8.55	-5.89	-24.90	158.99	-9.35
PS Ratio	1.74	13.08	14.42	34.58	59.25	8.65
PB Ratio	0.54	3.74	3.29	5.71	13.93	14.32
P/FCF Ratio	-4.03	-9.79	-6.61	-38.54	253.18	-9.69
P/OCF Ratio	-4.18	-10.12	-7.03	-40.60	239.69	-10.04
EV/Sales Ratio	3.58	14.59	15.77	33.88	55.73	8.79
EV/EBITDA Ratio	-5.28	-10.55	-7.17	-17.64	112.82	-11.16
EV/EBIT Ratio	-4.67	-9.63	-6.76	-16.86	148.20	-9.80
EV/FCF Ratio	-5.51	-10.91	-7.23	-37.76	238.14	-9.84
Debt / Equity Ratio	1.44	1.33	1.68	1.21	0.13	1.12
Debt / EBITDA Ratio	-3.58	-3.37	-3.35	-3.80	1.08	-0.86
Debt / FCF Ratio	-3.74	-3.48	-3.38	-8.14	2.27	-0.76
Quick Ratio	8.12	7.03	3.01	14.91	8.74	1.32
Current Ratio	9.28	7.81	3.24	15.36	9.24	1.65
Asset Turnover	0.11	0.11	0.07	0.08	0.27	0.56
Interest Coverage	-20.58	-21.18	-20.39	-20.94	111.12	-31.22
Return on Equity (ROE)	-43.10%	-43.80%	-48.20%	-33.40%	20.80%	-121.70%
Return on Assets (ROA)	-16.60%	-16.60%	-17.00%	-11.10%	10.10%	-51.80%
Return on Capital (ROIC)	-20.36%	-19.54%	-20.19%	-12.00%	-27.65%	-86.24%
Earnings Yield	-85.16%	-11.69%	-16.99%	-4.02%	0.63%	-10.70%
FCF Yield	-71.47%	-10.22%	-15.14%	-2.59%	0.39%	-10.32%
Buyback Yield / Dilution	-11.38%	-12.95%	-10.00%	-16.67%	-14.71%	-12.90%
Total Shareholder Return	-11.38%	-12.95%	-10.00%	-16.67%	-14.71%	-12.90%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).